Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence ALHNHYTQKSLSLSPG
Primary information
sequence IDSeq_528
Peptide sequenceALHNHYTQKSLSLSPG
CancerPDF_ID CancerPDF_ID9796, CancerPDF_ID10296,
PMID21533267,21805675
Protein NameIg gamma-2 chain C region,Ig gamma-1 chain C region
UniprotKB Entry NameIGHG2_HUMAN,IGHG1_HUMAN
FluidSerum,Urine
M/Z584.97,1752.8875
Charge3,NA
Mass (in Da)NA,NA
fdrNA,NA
Profiling TechniqueLC-MS,MALDI-TOF
Peptide Identification techniqueLC/MS/MS,MALDI-TOF-MS
Quantification TechniqueMultiple Reaction Monitoring,NA
Labelled/Label FreeLabel Free,Label Free
FDR1.49,1
CancerPDF_ID CancerPDF_ID9796, CancerPDF_ID10296,
p-ValueNA,NA
SoftwareMASCOT,NA
Length16,16
Cancer TypeLung adenocarcinoma,Muscle-invasive bladder cancer
DatabaseSwissprot Database (57.4),SwissProt Database
ModificationNA,NA
Number of Patients62 lung adenocarcinoma and 30 healthy control,751 bladder cancer and 127 control
Regulation"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal",Differentially expressed between cancer vs normal samples
ValidationMRM-based validation of 19 candidates,Mann-Whitney tests and areas under receiver-operator characteristic
SensitivityNA,NA
SpecificityNA,NA
AccuracyNA,NA
Peptide AtlasNA
IEDB